2017
DOI: 10.1016/j.brachy.2017.01.008
|View full text |Cite
|
Sign up to set email alerts
|

The value of systematic contouring of the bowel for treatment plan optimization in image-guided cervical cancer high-dose-rate brachytherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
3
0
3

Year Published

2017
2017
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 20 publications
1
3
0
3
Order By: Relevance
“…In this same sense, Damato establishes 65 Gy as the limit for bowel D2cc (EQD2 with an alpha/beta of 3), alluding that, in the EMBRACE study, the prescription dose at HR CTV (high risk clinical target volume) D90 was 85 Gy (as external radiotherapy plus brachytherapy integral dose), while at his institution, this prescription was generally lower than 80 Gy 19 .…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…In this same sense, Damato establishes 65 Gy as the limit for bowel D2cc (EQD2 with an alpha/beta of 3), alluding that, in the EMBRACE study, the prescription dose at HR CTV (high risk clinical target volume) D90 was 85 Gy (as external radiotherapy plus brachytherapy integral dose), while at his institution, this prescription was generally lower than 80 Gy 19 .…”
Section: Discussionmentioning
confidence: 93%
“…The benefit of contouring the small intestine that is not adjacent to the applicator as an organ at risk is controversial, which is why most institutions only contour the intestinal loops near the applicator 19 . In our study, contouring both the intestinal loops close to the applicator and those potentially susceptible to receive a moderate radiation dose (up to 2 cm from the applicator) was preferred.…”
Section: Discussionmentioning
confidence: 99%
“…En este mismo sentido, Damato establece como límite para la D2cc intestino 65 Gy (EQD2 con un alfa/ beta de 3) aludiendo a que en el estudio EMBRACE las dosis de prescripción al D90 del HR CTV (volumen blanco clínico de alto riesgo) era de 85 Gy (como dosis integral radioterapia externa con braquiterapia), mientras que en su institución esta prescripción era más baja en general de 80 Gy 19 .…”
Section: Discussionunclassified
“…El beneficio de contornear como órgano de riesgo el intestino delgado que no se encuentra adyacente al aplicador es controvertido, motivo por el que la mayoría de las instituciones solo realizan el contorneo de las asas intestinales cercanas al aplicador 19 . En nuestro estudio se prefirió realizar el contorneo tanto de las asas intestinales cercanas al aplicador como de aquellas potencialmente susceptibles de recibir una dosis moderada de radiación (hasta 2 cm del aplicador).…”
Section: Discussionunclassified
See 1 more Smart Citation